mci 9038 and fibrin
mci 9038 has been researched along with fibrin in 15 studies
Research
Studies (15)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Imanishi, Y; Ito, Y; Liu, LS; Matsuo, R | 1 |
| Atagi, S; Fukuta, K; Ogura, T; Sone, S | 1 |
| Berry, CN; Girardot, C; Lecoffre, C; Lunven, C | 1 |
| Hijikata-Okunomiya, A; Okamoto, S | 1 |
| Berry, CN; Gauffeny, C; Lecoffre, C; Lunven, C; O'Brien, DP; Roome, NO | 1 |
| Hantgan, RR; Hursting, MJ; Jerome, WG | 1 |
| Ataullakhanov, FI; Krasotkina, YV; Sinauridze, EI | 1 |
| Maeno, T; Mano, T; Takenaka, H; Tano, Y | 1 |
| Berens, KL; Brown, PM; Chopp, M; Lu, M; Morris, DC; Zhang, L; Zhang, ZG | 1 |
| Hijikata-Okunomiya, A; Kataoka, N | 1 |
| Hamada, M; Matsui, H; Mizuno, T; Shida, Y; Sugimoto, M; Yoshioka, A | 1 |
| Buerke, M; Busshardt, M; Ebelt, H; Kaeberich, A; Maegdefessel, L; Plehn, A; Raaz, U; Russ, M; Schlitt, A; Schubert, S; Werdan, K | 1 |
| Bark, N; Blombäck, M; He, S; Johnsson, H; Wallén, NH | 1 |
| Fredenburgh, JC; Leslie, BA; Stafford, AR; Weitz, JI; Yeh, CH | 1 |
| Arai, N; Matsumoto, T; Nogami, K; Ogiwara, K; Sasai, K; Shima, M | 1 |
Other Studies
15 other study(ies) available for mci 9038 and fibrin
| Article | Year |
|---|---|
Synthesis and nonthrombogenicity of polymer membrane with surface-graft polymers carrying thrombin inhibitor.
Topics: Acrylamides; Amino Acid Sequence; Animals; Antithrombins; Arginine; Blood Coagulation; Blood Coagulation Tests; Blood Grouping and Crossmatching; Dogs; Fibrin; Membranes, Artificial; Molecular Sequence Data; Molecular Structure; Pipecolic Acids; Platelet Adhesiveness; Platelet Aggregation; Polymers; Solutions; Sulfonamides; Surface Properties | 1992 |
Inhibition by fibrin coagulation of lung cancer cell destruction by human interleukin-2-activated killer cells.
Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Blood Coagulation; Cell Death; Cytotoxicity, Immunologic; Female; Fibrin; Fibrinogen; Humans; Immunity, Cellular; Interleukin-2; Killer Cells, Lymphokine-Activated; Kinetics; Leukocytes, Mononuclear; Lung Neoplasms; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombin | 1992 |
Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.
Topics: Antithrombins; Arginine; Blood Coagulation; Dipeptides; Dose-Response Relationship, Drug; Fibrin; Heparin; Hirudins; Humans; Pipecolic Acids; Recombinant Proteins; Sulfonamides; Thrombin | 1994 |
Synthetic selective inhibitors of thrombin.
Topics: Amino Acid Sequence; Animals; Antithrombin III; Antithrombins; Arginine; Cattle; Dansyl Compounds; Fibrin; Fibrinogen; Heparin; Humans; Infant, Newborn; Kinetics; Molecular Sequence Data; Molecular Structure; Oligopeptides; Pipecolic Acids; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Thrombin | 1993 |
Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin.
Topics: Animals; Antithrombin III; Antithrombins; Arginine; Fibrin; Fibrinolytic Agents; Heparin; Hirudins; Pipecolic Acids; Platelet Activation; Platelet Aggregation Inhibitors; Rabbits; Recombinant Proteins; Sulfonamides; Thrombosis | 1996 |
No effect of clot age or thrombolysis on argatroban's inhibition of thrombin.
Topics: Arginine; Blood Coagulation; Blood Coagulation Tests; Fibrin; Fibrinolysis; Humans; Models, Biological; Perfusion; Pipecolic Acids; Streptokinase; Sulfonamides; Thrombin; Time Factors; Tissue Plasminogen Activator | 1998 |
Spatiotemporal dynamics of fibrin formation and spreading of active thrombin entering non-recalcified plasma by diffusion.
Topics: alpha-Macroglobulins; Antithrombins; Arginine; Blood Coagulation; Calcium; Coumarins; Diffusion; Fibrin; Fibrinogen; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Kinetics; Models, Theoretical; Pipecolic Acids; Plasma; Solutions; Sulfonamides; Thrombin | 2000 |
Argatroban inhibits intraocular fibrin formation after vitrectomy in rabbits.
Topics: Animals; Anterior Chamber; Antithrombins; Arginine; Dose-Response Relationship, Drug; Fibrin; Lens, Crystalline; Ophthalmic Solutions; Pipecolic Acids; Postoperative Complications; Rabbits; Sulfonamides; Time Factors; Vitrectomy; Vitreous Body | 2000 |
Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
Topics: Animals; Antithrombins; Arginine; Brain Ischemia; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Fibrin; Incidence; Infarction, Middle Cerebral Artery; Intracranial Embolism; Male; Pipecolic Acids; Rats; Rats, Wistar; Recombinant Proteins; Stroke; Sulfonamides; Time Factors; Tissue Plasminogen Activator | 2001 |
Argatroban inhibits staphylothrombin.
Topics: Arginine; Blood Coagulation; Coagulase; Fibrin; Humans; Pipecolic Acids; Staphylococcus aureus; Sulfonamides; Thrombin | 2003 |
Visual evaluation of blood coagulation during mural thrombogenesis under high shear blood flow.
Topics: Adult; Anticoagulants; Arginine; Blood Coagulation; Blood Flow Velocity; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Factor VIIa; Fibrin; Hemolysis; Hemophilia A; Hemorheology; Heparin; Humans; Male; Microscopy, Confocal; Microscopy, Electron, Scanning; Middle Aged; Perfusion; Pipecolic Acids; Sulfonamides; Surface Properties; Thrombosis | 2008 |
The direct thrombin inhibitor argatroban effectively prevents cardiac catheter thrombosis in vitro.
Topics: Anticoagulants; Antithrombin III; Arginine; Blood Coagulation; Blood Platelets; Cardiac Catheterization; Enoxaparin; Factor Xa; Factor Xa Inhibitors; Fibrin; Heparin; Humans; Male; Peptide Hydrolases; Pipecolic Acids; Stress, Mechanical; Sulfonamides; Thrombin; Thrombosis; Time Factors | 2010 |
The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis.
Topics: Antithrombins; Arginine; Chondroitin Sulfates; Chromatography, Gel; Dermatan Sulfate; Factor VIII; Factor Xa Inhibitors; Fibrin; Fibrinolysis; Heparinoids; Heparitin Sulfate; Hirudins; Humans; In Vitro Techniques; Microscopy, Confocal; Peptide Fragments; Pipecolic Acids; Plasma; Porosity; Protein Multimerization; Recombinant Proteins; Sulfonamides; Thrombosis; Tissue Plasminogen Activator | 2010 |
Dabigatran and Argatroban Diametrically Modulate Thrombin Exosite Function.
Topics: Allosteric Regulation; Antithrombins; Arginine; Binding Sites; Biocatalysis; Blood Coagulation; Catalytic Domain; Dabigatran; Fibrin; Fibrinogen; Humans; Pipecolic Acids; Protein Binding; Substrate Specificity; Sulfonamides; Surface Plasmon Resonance; Thrombin | 2016 |
A novel simultaneous clot-fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders.
Topics: Arginine; Fibrin; Fibrin Clot Lysis Time; Fibrinolysis; Hemorrhagic Disorders; Humans; Kinetics; Pipecolic Acids; Sulfonamides; Thrombomodulin; Tranexamic Acid | 2019 |